Loading...

A100 THE UNFINISHED SYMPHONY: GOLIMUMAB IS EFFICIENT AS SALVAGE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE

BACKGROUND: Golimumab is a fully human, IgG1k monoclonal antibody against anti–tumor necrosis factor (anti-TNF) agent approved for the treatment of moderate-to-severely active ulcerative colitis. However, there have been no formal trials to date to assess its utility in Crohn’s disease (CD). AIMS: T...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Can Assoc Gastroenterol
Main Authors: Greener, T, Greenberg, G, Steinhart, H, Silverberg, M S
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507753/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.101
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!